IHT Wealth Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-19,700
| Closed | -$73.9K | – | 1060 |
|
|
2024
Q1 | $73.9K | Hold |
19,700
| – | – | ﹤0.01% | 982 |
|
|
2023
Q4 | $193K | Hold |
19,700
| – | – | 0.01% | 913 |
|
|
2023
Q3 | $164K | Sell |
19,700
-1,000
| -5% | -$8.35K | 0.01% | 896 |
|
|
2023
Q2 | $275K | Hold |
20,700
| – | – | 0.01% | 755 |
|
|
2023
Q1 | $240K | Hold |
20,700
| – | – | 0.01% | 775 |
|
|
2022
Q4 | $169K | Hold |
20,700
| – | – | 0.01% | 834 |
|
|
2022
Q3 | $120K | Buy |
20,700
+2,000
| +11% | +$11.6K | 0.01% | 815 |
|
|
2022
Q2 | $83K | Buy |
18,700
+1,000
| +6% | +$4.44K | 0.01% | 707 |
|
|
2022
Q1 | $161K | Hold |
17,700
| – | – | 0.01% | 724 |
|
|
2021
Q4 | $362K | Buy |
17,700
+5,039
| +40% | +$103K | 0.03% | 540 |
|
|
2021
Q3 | $323K | Buy |
12,661
+2,613
| +26% | +$66.7K | 0.03% | 569 |
|
|
2021
Q2 | $351K | Sell |
10,048
-580
| -5% | -$20.3K | 0.02% | 647 |
|
|
2021
Q1 | $354K | Sell |
10,628
-1,691
| -14% | -$56.3K | 0.03% | 568 |
|
|
2020
Q4 | $320K | Buy |
12,319
+1,923
| +18% | +$50K | 0.03% | 539 |
|
|
2020
Q3 | $103K | Buy |
+10,396
| New | +$103K | 0.01% | 630 |
|
|
2018
Q4 | – | Sell |
-67,450
| Closed | -$365K | – | 506 |
|
|
2018
Q3 | $365K | Sell |
67,450
-18,043
| -21% | -$97.6K | 0.08% | 286 |
|
|
2018
Q2 | $304K | Sell |
85,493
-757
| -0.9% | -$2.69K | 0.08% | 301 |
|
|
2018
Q1 | $182K | Hold |
86,250
| – | – | 0.05% | 361 |
|
|
2017
Q4 | $235K | Buy |
+86,250
| New | +$235K | 0.06% | 323 |
|